Press Announcements - FDA.gov

1. Press Announcements  FDA.gov
2. UPDATED: Once spurned, Amgen wins the FDA over with its bone-building osteoporosis drug Evenity  Endpoints News
3. FDA OKs Romosozumab for Postmenopausal Osteoporosis  Medscape
4. FDA approves new osteoporosis drug for postmenopausal women  CNN
5. FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture  PRNewswire
6. View full coverage on Google News

from Business - Latest - Google News http://bit.ly/2KjRlbZ